The Effects of Faculty/Staff Exercise Program

The Physiological and Cognitive Effects of Faculty/Staff Exercise Program in a University Setting

This study focuses on analyzing the data collected from participants in the Faculty/Staff Exercise Program to determine the success and quantifying the results of the program. The investigators are interested in the effectiveness of this program on multiple levels, individual and group, as it is the first of its kind - an exercise program targeting the faculty and staff at a university.

Study Overview

• Status: Completed
• Conditions: Physical Activity; Sedentary Lifestyle; Cardiovascular Risk Factor
• Intervention / Treatment: Behavioral: Physical Activity

Detailed Description

This study focuses on analyzing the data collected from participants in the Faculty/Staff Exercise Program to determine the success and quantifying the results of the program. The investigators are interested in the effectiveness of this program on multiple levels, individual and group, as it is the first of its kind - an exercise program targeting the faculty and staff at a university. Participants were regular attendees in either a 6am or 12pm exercise program session. Data included both measures of physical health as well as cognitive health. Measures of physical health included the assessment of body fat using the skin-fold method of analysis (3-site). Cholesterol was measured via blood draw analysis. This was done at the Kent State University Exercise Physiology Laboratory by certified research staff. A 6 minute walk test was completed to measure aerobic capacity. Flexibility was assessed via the sit-and-reach test while anaerobic strength and endurance were assessed using sit-up and curl-up tests. Assessment of balance was done using a Biodex Balance System.

Assessments of cognitive health included several questionnaires that asked questions related to sleep habits, stress levels, and mood. In addition, each participant was given a MOVband to track physical activity. The device was worn during waking hours for all days of participation.The data from the MOVband was auto-uploaded to a computer program for tracking so that no manual entry was necessary.

• Study Type: Interventional
• Enrollment (Actual): 50
• Phase: Not Applicable

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 21 years to 65 years (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• age 21-65 years
• current faculty/staff member
• no contraindications to exercise
• sedentary prior to enrollment

Exclusion Criteria:

• age <21 years, >65 years
• non faculty/staff member
• contraindications to exercise
• regular exercise participation prior to enrollment

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Physical Activity; Participants were subjected to a 12-week exercise program targeting the federal physical activity guidelines.	Behavioral: Physical Activity; Participants underwent 12-weeks of exercise prescription aimed at the federal guidelines (3 days/week).

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Height	Objectively measured height in meters using a standard clinical stadiometer.	Assessed once at baseline.
Weight	Objectively measured weight in kilograms using a standard clinical scale.	Change from baseline weight at 4-weeks, 8-weeks, and 12-weeks follow-up.
Systolic Blood Pressure	Objectively measured systolic blood pressure in millimeters of Mercury using a standard Mercury sphygmomanometer.	Change from baseline systolic blood pressure at 4-weeks, 8-weeks, and 12-weeks follow-up.
Diastolic Blood Pressure	Objectively measured diastolic blood pressure in millimeters of Mercury using a standard Mercury sphygmomanometer.	Change from baseline diastolic blood pressure at 4-weeks, 8-weeks, and 12-weeks follow-up.
High-Density Lipoprotein	Objectively measured high-density lipoprotein in milligrams per deciliter using a standard assay kit.	Change from baseline high-density lipoprotein at 4-weeks, 8-weeks, and 12-weeks follow-up.
Low-Density Lipoprotein	Objectively measured low-density lipoprotein in milligrams per deciliter using a standard assay kit.	Change from baseline low-density lipoprotein at 4-weeks, 8-weeks, and 12-weeks follow-up.
Total Serum Cholesteral	Objectively measured total serum cholesterol in milligrams per deciliter using a standard assay kit.	Change from baseline total serum cholesterol at 4-weeks, 8-weeks, and 12-weeks follow-up.
Impaired Fasting Glucose	Objectively measured impaired fasting glucose in milligrams per deciliter using a standard assay kit.	Change from baseline impaired fasting glucose at 4-weeks, 8-weeks, and 12-weeks follow-up.

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Accelerometer-Based Physical Activity	Assessment of accelerometer-based physical activity outcome measures (e.g., steps per day).	Change from baseline accelerometer-based physical activity 4-weeks, 8-weeks, and 12-weeks follow-up using 1-minute epochs.

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
Sleep Quality (Pittsburgh Sleep Quality Index)	The Pittsburgh Sleep Quality Index (PSQI) is a self-report questionnaire that assesses sleep quality over a 1-month time interval.	Change from baseline sleep quality at 4-weeks, 8-weeks, and 12-weeks follow-up.
Depression (Depression, Anxiety, and Stress Scale-21)	The depression, anxiety, and stress scale-21 (DASS-21) is a clinical assessment that measures the three related states of depression, anxiety and stress.	Change from baseline depression at 4-weeks, 8-weeks, and 12-weeks follow-up.
Anxiety (Depression, Anxiety, and Stress Scale-21)	The depression, anxiety, and stress scale-21 (DASS-21) is a clinical assessment that measures the three related states of depression, anxiety and stress.	Change from baseline anxiety at 4-weeks, 8-weeks, and 12-weeks follow-up.
Stress (Depression, Anxiety, and Stress Scale-21)	The depression, anxiety, and stress scale-21 (DASS-21) is a clinical assessment that measures the three related states of depression, anxiety and stress.	Change from baseline stress at 4-weeks, 8-weeks, and 12-weeks follow-up.
Mood (Profile of Mood States)	The Profile of Mood States (POMS) is a psychological rating scale used to assess transient, distinct mood states.	Change from baseline mood at 4-weeks, 8-weeks, and 12-weeks follow-up.
Quality of Life (36-Item Short Form Survey)	The 36-item short form survey (SF-36) is a set of generic, coherent, and easily administered quality-of-life measures.	Change from baseline quality of life at 4-weeks, 8-weeks, and 12-weeks follow-up.

Collaborators and Investigators

• Sponsor: Kent State University
• Investigators: Study Director: Duane B Corbett, PhD, Kent State University

Publications and helpful links

General Publications

• Corbett DB, Fennell C, Peroutky K, Kingsley JD, Glickman EL. The effects of a 12-week worksite physical activity intervention on anthropometric indices, blood pressure indices, and plasma biomarkers of cardiovascular disease risk among university employees. BMC Res Notes. 2018 Jan 29;11(1):80. doi: 10.1186/s13104-018-3151-x.

Study record dates

Study Major Dates

• Study Start (Actual): June 26, 2013
• Primary Completion (Actual): October 11, 2013
• Study Completion (Actual): October 11, 2013

Study Registration Dates

• First Submitted: December 4, 2017
• First Submitted That Met QC Criteria: December 20, 2017
• First Posted (Actual): December 28, 2017

Study Record Updates

• Last Update Posted (Actual): December 28, 2017
• Last Update Submitted That Met QC Criteria: December 20, 2017
• Last Verified: December 1, 2017

More Information

Terms related to this study

• Other Study ID Numbers: 13-329

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No